Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 10 | 14 | 13 | 12 | 199 |
| Accounts receivable | -68 | 8 | 217 | 74 | -173 |
| Accounts payable and accrued liabilities | N/A | N/A | -106 | -867 | 50 |
| Other Working Capital | 1,333 | 485 | 186 | -892 | -54 |
| Other Operating Activity | -5,106 | -5,726 | -5,837 | -4,836 | -9,326 |
| Operating Cash Flow | $-3,831 | $-5,219 | $-5,527 | $-6,509 | $-9,304 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 17 | -14 | -5 | N/A | N/A |
| Net Acquisitions | N/A | N/A | N/A | 0 | 2,020 |
| Investing Cash Flow | $17 | $-14 | $-5 | $0 | $2,020 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | -2,062 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 0 | 3,159 |
| Debt Repayment | N/A | N/A | N/A | 0 | -158 |
| Common Stock Issued | 2,685 | 5,506 | 4,151 | 2,994 | 3,561 |
| Other Financing Activity | 113 | 0 | 999 | 3,211 | 0 |
| Financing Cash Flow | $2,798 | $5,506 | $3,088 | $6,205 | $6,562 |
| Exchange Rate Effect | N/A | N/A | 0 | -9 | 52 |
| Beginning Cash Position | 1,081 | 808 | 3,252 | 3,565 | 4,235 |
| End Cash Position | 65 | 1,081 | 808 | 3,252 | 3,565 |
| Net Cash Flow | $-1,016 | $273 | $-2,444 | $-304 | $-722 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,831 | -5,219 | -5,527 | -6,509 | -9,304 |
| Capital Expenditure | -2 | -14 | -10 | N/A | N/A |
| Free Cash Flow | -3,833 | -5,233 | -5,537 | -6,509 | -9,304 |